+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

How nitrate tolerance be prevented in the treatment of ischemic heart disease?



How nitrate tolerance be prevented in the treatment of ischemic heart disease?



Wiadomosci Lekarskie 53(11-12): 664-669



Organic nitrates are widely used for chronic treatment of ischaemic heart disease. However, the clinical value of long-term nitrate therapy is limited by the development of tolerance to their anti-anginal effects. This paper examines the different effects of nitrates, especially cellular effects. The theories put forward to explain nitrate tolerance are examined, including recent work on vascular superoxide and endothelin-1 regulation. Clinically, tolerance can be prevented by intermitted dosing of nitrates. This topic, and the practical results of work using other pharmacologic interventions in a clinical setting are discussed in the final section of this article.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046280393

Download citation: RISBibTeXText

PMID: 11247410


Related references

Nitrate tolerance and endothelial dysfunction during continuous nitrate therapy in patients with ischemic heart disease. Circulation 100(18 Suppl. ): I 186-I 187, 1999

Fluvastatin attenuates nitrate tolerance in patients with ischemic heart disease complicating hypercholesterolemia. International Journal of Cardiology 90(2-3): 181-188, 2003

Nitrate tolerance and nitroglycerin-induced endothelial dysfunction in diabetic patients with ischemic heart disease. Circulation 108(17 Suppl.): IV-564, 2003

Smoking and the development of nitrate tolerance in patients with ischemic heart disease - antioxidant deficiency in smokers. Circulation 98(17 Suppl. ): I851-I852, 1998

Effectiveness and tolerance of "Lignocainum hydrochloricum" in the treatment of arrhythmia in ischemic heart disease. Wiadomosci Lekarskie 36(22): 1837-1842, 1983

Ischemic heart disease. Advances in diagnosis and treatment I. Epidemiology and disease state 3. Vascular endothelial cell failure and ischemic heart disease. Nihon Naika Gakkai Zasshi 89(2): 224-230, 2000

Tolerance of ischemic heart disease patients for treatment of concurrent diseases with decimeter waves. Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury .(5): 76-77, 1978

Tolerance of physical exertion among patients with chronic ischemic heart disease during treatment with butadione. Vrachebnoe Delo 1986(5): 53-56, 1986

Hemodynamics, gas exchange and tolerance to physical exertion during treatment of ischemic heart disease with nerobolil. Vrachebnoe Delo 1977(10): 67-70, 1977

Several indices of hemodynamics, gas exchange and exercise tolerance during treatment of ischemic heart disease with obsidan. Kardiologiia 16(12): 62-66, 1976

Ischemic heart disease. Advances in diagnosis and treatment I. Epidemiology and disease state 4. Insulin resistance and ischemic heart disease. Nihon Naika Gakkai Zasshi 89(2): 231-236, 2000

Nitrate tolerance--can it be prevented?. European Heart Journal 12 Suppl A: 13-15, 1991

Ischemic heart disease : an advance of diagnosis and medical treatment.1.Epidemiology and origin.3.Origin and disease state of ischemic heart disease.Atgeris clerosis and spasm. Nihon Naika Gakkai Zasshi 79(11): 1497-1500, 1990

Effect of xamoterol corwin on exercise tolerance and heart rate in patients with heart failure secondary to ischemic heart disease. American Heart Association Monograph (114): III-473, 1985

Ischemic heart disease : an advance of diagnosis and treatment.I.Epidemiology and causes.I.Does ischemic heart disease increase ?. Nihon Naika Gakkai Zasshi 79(11): 1485-1490, 1990